Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Johannes Irsch"'
Autor:
Rafael R. de Assis, Aarti Jain, Rie Nakajima, Algis Jasinskas, Jiin Felgner, Joshua M. Obiero, Philip J. Norris, Mars Stone, Graham Simmons, Anil Bagri, Johannes Irsch, Martin Schreiber, Andreas Buser, Andreas Holbro, Manuel Battegay, Philip Hosimer, Charles Noesen, Oluwasanmi Adenaiye, Sheldon Tai, Filbert Hong, Donald K. Milton, D. Huw Davies, Paul Contestable, Laurence M. Corash, Michael P. Busch, Philip L. Felgner, Saahir Khan
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-9 (2021)
COVID-19 diagnosis is commonly performed by PCR testing, however, serologic methods are more accurate and versatile for monitoring disease burden and epidemiology. Here the authors report a protein microarray with antigens from SARS-CoV-2, SARS-CoV,
Externí odkaz:
https://doaj.org/article/307aa88ea3a740b187cbbb0355b0645c
Autor:
Maja Weisser, Nina Khanna, Anemone Hedstueck, Sarah Tschudin Sutter, Sandra Roesch, Gregor Stehle, Mihaela Sava, Nikolaus Deigendesch, Manuel Battegay, Laura Infanti, Andreas Holbro, Stefano Bassetti, Hans Pargger, Hans H. Hirsch, Karoline Leuzinger, Laurent Kaiser, Diem‐Lan Vu, Katharina Baur, Nadine Massaro, Michael Paul Busch, Graham Simmons, Mars Stone, Philip L. Felgner, Rafael R. de Assis, Saahir Khan, Cheng‐ting Tsai, Peter V. Robinson, David Seftel, Johannes Irsch, Anil Bagri, Andreas S. Buser, Laurence Corash
Publikováno v:
Transfusion. 62(10)
Efficacy of donated COVID-19 convalescent plasma (dCCP) is uncertain and may depend on antibody titers, neutralizing capacity, timing of administration, and patient characteristics.In a single-center hypothesis-generating prospective case-control stu
Publikováno v:
Transfusion. 62(8)
Autor:
Felicia Santa Maria, Peter Bringmann, Johannes Irsch, Marion Lanteri, Jean-Marc Payrat, Nina Mufti, Laurence Corash
Publikováno v:
Transfusion Clinique et Biologique. 29:361
Autor:
Ottar Rolfsson, Johannes Irsch, Olafur E. Sigurjonsson, Niels Arni Arnason, Björn Hardarsson, Sveinn Vidar Gudmundsson, Ragna Landrö, Freyr Johannson
Publikováno v:
Transfusion. 59:3727-3735
Background To reduce the risk of transfusion transmission infection, nucleic acid targeted methods have been developed to inactivate pathogens in PCs. miRNAs have been shown to play an important role in platelet function, and changes in the abundance
Autor:
Johannes Irsch, David Tappe, Daniel Bolliger, Andreas Holbro, Laurence Corash, Jin-Sying Lin, Jakob Passweg, Richard J. Benjamin, Ramona Merki, Laura Infanti, Alexandra Plattner, Andreas Buser, Dimitrios A. Tsakiris
Publikováno v:
Transfusion
BACKGROUND Universal pathogen inactivation of platelet concentrates (PCs) using amotosalen/ultraviolet A with 7-day storage was implemented in Switzerland in 2011. Routine-use data were analyzed at the University Hospital Basel, Switzerland. STUDY DE
Publikováno v:
Transfusion and Apheresis Science. 61:103404
Transfusion-associated graft versus host disease (TA-GVHD) is a highly morbid and often fatal adverse event associated with transfusion of cellular blood products [platelets, red blood cells (RBCs) and whole blood] and more rarely with never-frozen p
Autor:
Jean-Marc Payrat, Yvette A. Girard, Johannes Irsch, Marion C. Lanteri, Andrew Laughhunn, Marcus Picard-Maureau, Adonis Stassinopoulos, Felicia Santa‐Maria, Peter Bringmann
Publikováno v:
Transfusion
Background The INTERCEPT Blood System pathogen reduction technology (PRT), which uses amotosalen and ultraviolet A light treatment (amotosalen/UV-PRT), inactivates pathogens in plasma and platelet components (PCs). This review summarizes data describ
Autor:
Jiin Felgner, Martin A. Schreiber, Oluwasanmi Adenaiye, Rafael Ramiro de Assis, Johannes Irsch, Donald K. Milton, D. Huw Davies, Algis Jasinskas, Philip Hosimer, Rie Nakajima, Anil Bagri, S.-H. Sheldon Tai, Philip L. Felgner, Philip J. Norris, Aarti Jain, Filbert Hong, Paul B. Contestable, Graham Simmons, Andreas Holbro, Michael P. Busch, Charles Noesen, Laurence Corash, Andreas Buser, Mars Stone, Joshua M. Obiero, Manuel Battegay, Saahir Khan
Publikováno v:
Nature Communications
bioRxiv
article-version (status) pre
article-version (number) 1
Nature Communications, Vol 12, Iss 1, Pp 1-9 (2021)
Nature Communications, vol 12, iss 1
bioRxiv
article-version (status) pre
article-version (number) 1
Nature Communications, Vol 12, Iss 1, Pp 1-9 (2021)
Nature Communications, vol 12, iss 1
The current practice for diagnosis of COVID-19, based on SARS-CoV-2 PCR testing of pharyngeal or respiratory specimens in a symptomatic patient at high epidemiologic risk, likely underestimates the true prevalence of infection. Serologic methods can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddf4d0725e2018b8de832287c31b5e4e
https://doi.org/10.1101/2020.04.15.043364
https://doi.org/10.1101/2020.04.15.043364
Autor:
Jean-Marc Payrat, Marcus Picard-Maureau, Marion C. Lanteri, Felicia Santa Maria, Peter Bringmann, Johannes Irsch, Thea Lu, Yvette A. Girard
Publikováno v:
Transfusion Clinique et Biologique. 28:S60
Introduction INTERCEPT Blood System utilise l’amotosalen et les UVA (IA) pour attenuer les agents pathogenes et les leucocytes dans le plasma et les plaquettes. Objectif Resumer les donnees obtenues quant a l’efficacite du systeme pour inactiver